Oscar Health Financials - Benzinga

Oscar Health Inc

OSCRNYSE

Trade with Public

Trade with Public

$29.60

0.732.53%

In chiusura: Sep 25, 5:00 PM EST

$29.61

0.00540.02%

Post-mercato: 7:53 PM EST

Panoramica Notizie Previsioni utili Eventi Obiettivi di prezzoDati finanziariSentiment Azionariato Confronta Opzioni Rapporto azionario

Oscar Health Financials

Oscar Health (OSCR) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

Oscar Health Raises Outlook But Warns CMS Membership Churn Will Pick Up

Oscar Health (OSCR) beat Q2 earnings with $4.88B revenue, but shares fell on expected ACA membership churn in H2. Read more.

Vandana Singh

PRO
Oscar Health Affirms FY2026 Sales Guidance of $18.700B-$19.000B vs $18.623B Est

Oscar Health (NYSE:OSCR) affirms FY2026 sales outlook from $18.700 billion-$19.000 billion to $18.700 billion-$19.000 billion vs $18.623 billion estimate.

Benzinga Newsdesk

PRO
Oscar Health Q2 Total Members 2.963M (+46$ Y/Y)

As of June 30, Effectuated Membership by Offering2026 2025 Individual and Small Group (1)2,963,002 2,017,058 Cigna+Oscar (2)— 10,090 Total Members (3)2,963,002 2,027,148

Benzinga Newsdesk

PRO
Oscar Health Q2 EPS $1.10 Beats $0.49 Estimate, Sales $4.882B Beat $4.751B Estimate

Oscar Health (NYSE:OSCR) reported quarterly earnings of $1.10 per share which beat the analyst consensus estimate of $0.49 by 120 percent. This is a 223.6 percent increase over losses of $(0.89) per share from the same

Benzinga Newsdesk

Elevance Health's Small Outlook Boost Disappoints, Stock Sinks

Elevance Health (ELV) beats Q2 expectations but triggers a broader managed-care selloff after a conservative guidance raise.

Vandana Singh

Earnings Scheduled For May 6, 2026

Benzinga Insights

© 2026 Benzinga | All Rights Reserved